Age dependence of endogenous galactose formation in Q188R homozygous galactosemic patients

Molecular Genetics and Metabolism

Volumn 81, Issue 1, 2004, Pages 31-44

  Schadewaldt, Peter ^a   Kamalanathan, Loganathan ^a   Hammen, Hans Werner ^a   Wendel, Udo ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Carbon isotopes; Galactitol; Galactokinase; Galactonic acid; Galactose; Galactose 1 phosphate uridyltransferase; Galactosemia; Human; Metabolism

Indexed keywords

ARGININE; GALACTITOL; GALACTOSE; GALACTOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; GLUTAMINE; ISOTOPE;

ABSORPTION; ADOLESCENT; ADULT; AGE; AMINO ACID SUBSTITUTION; ARTICLE; ASSAY; BODY WEIGHT; CARBOHYDRATE SYNTHESIS; CHEMICAL PARAMETERS; CHILD; CLINICAL ARTICLE; CONTINUOUS INFUSION; DIET RESTRICTION; DIET THERAPY; ERYTHROCYTE; FEMALE; GALACTOSEMIA; HOMOZYGOSITY; HUMAN; MALE; MATHEMATICAL MODEL; METABOLISM; NONLINEAR SYSTEM; PATIENT; PLASMA; PRIORITY JOURNAL;

EID: 0347320580     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymgme.2003.10.007     Document Type: Article

References (35)

1. Wendel U., Kamalanathan L., Hammen H.-W., Schadewaldt P. Age dependence of endogenous galactose formation in Q188R-homozygous galactosemic patients. J. Inherit. Metab. Dis. 25(Suppl. 1):2002;131.
2. National Centre for Biotechnology Information. MIM No. 230400, Galactosemia. OMIMTM: Online Mendelian Inheritance in Man. Available from < http://www.ncbi.nlm.nih.gov/omim>.
3. von Reuss A. Zuckerausscheidung im Säuglingsalter. Wien. Med. Wochenschr. 58:1908;799-801.
4. Holton J.B., Walter J.H., Tyfield L.A. Galactosemia. Scriver C.R., Beaudet A.L., Sly W., Valle D., Childs B., Kinzler K.W., Vogelstein B. The Metabolic and Molecular Bases of Inherited Disease. 2001;1553-1587 McGraw-Hill, New York.
5. Gitzelmann R., Steinmann B. Galactosaemia: how does long-term treatment change the outcome? Enzyme. 32:1984;37-46.
6. Berry G.T., Nissim I., Lin Z., Mazur A.T., Gibson J.B., Segal S. Endogenous synthesis of galactose in normal men and patients with hereditary galactosaemia. Lancet. 346:1995;1073-1074.
7. 13C]galactose isotopic enrichment. Mol. Genet. Metab. 70:2000;261-271.
8. 13C enrichment of D-galactose in human plasma. Clin. Chem. 46:2000;612-619.
9. Schweitzer S., Shin Y., Jakobs C., Brodehl J. Long-term outcome in 134 patients with galactosaemia. Eur. J. Pediatr. 152:1993;36-43.
10. Hutchesson A.C.J., Murdoch-Davis C., Green A., Preece M.A., Allen J., Holton J.B., Rylance G. Biochemical monitoring of treatment for galactosaemia: biological variability in metabolite concentrations. J. Inherit. Metab. Dis. 22:1999;139-148.
11. Schadewaldt P., Killius S., Kamalanathan L., Hammen H.-W., Straßburger K., Wendel U. Renal excretion of galactose and galactitol in patients with classical galactosaemia, obligate heterozygous parents, and healthy subjects. J. Inherit. Metab. Dis. 25:2003;459-479.
12. Henderson J.M., Kutner M.H., Bain R.P. First-order clearance of plasma galactose: the effect of liver disease. Gastroenterology. 83:1982;1090-1096.
13. Jakobs C., Warner T.G., Sweetman L., Nyhan W.L. Stable isotope dilution analysis of galactitol in amniotic fluid: an accurate approach to the prenatal diagnosis of galactosemia. Pediatr. Res. 18:1984;714-718.
14. Dahlquist A. D-Galactose-1-phosphate. Bergmeyer H.U., Grassl M. Methods of Enzymatic Analysis. vol. VI:1983;297-303 Verlag Chemie, Weinheim.
15. Lehrfeld J. G.L.C. determination of aldonic acids as acetylated aldonamides. Carbohydr. Res. 135:1985;179-185.
16. Elsas L.J., Langley S., Steele E., Evinger J., Fridovich-Keil J.L., Brown A., Singh R., Fernhoff P., Hjelm L.N., Dembure P.P. Galactosemia: a strategy to identify new biochemical phenotypes and molecular genotypes. Am. J. Hum. Genet. 56:1995;630-639.
17. Shin Y.S. Galactose metabolites and disorders of galactose metabolism. Hommes F.A. Techniques in Diagnostic Human Biochemical Genetics. 1991;267-283 Wiley-Liss, New York.
18. Wahlefeld A.W., Siedel J. Creatine and creatinine. Bergmeyer H.U. Methods in Enzymatic Analysis. vol. VII:1985;488-506 Verlag Chemie, Weinheim.
19. 2 breath tests: methodology and fundamental considerations. J. Lab. Clin. Med. 90:1977;412-421.
20. 14C] pyruvate in normal, acromegalic, and HGH treated human subjects. Acta Endocrinol. 65:1970;155-169.
21. Haycock G., Schwartz G., Wisotsky D. Geometric method for measuring body surface area: a height-weight formula validated in infants, children and adults. J. Pediatr. 93:1978;62-66.
22. Allsop J.R., Wolfe R.R., Burke J.F. Tracer priming the bicarbonate pool. J. Appl. Physiol. 45:1978;137-139.
23. Acosta P.B., Gross K.C. Hidden sources of galactose in the environment. Eur. J. Pediatr. 154(Suppl. 2):1995;S87-S92.
24. Thompson G.N., Pacy P.J., Ford G.C., Halliday D. Practical considerations in the use of stable isotope labelled compounds as tracers in clinical studies. Biomed. Environ. Mass Spectrom. 18:1989;321-327.
25. Bergren W.R., Ng W.G., Donnell G.N. Galactonic acid in galactosemia: identification in the urine. Science. 176:1972;683-684.
26. Roe T.F., Ng W.G., Bergren W.R., Donnell G.N. Urinary galactitol in galactosemic patients. Biochem. Med. 7:1973;266-273.
27. Ng W.G., Donell G.N., Bergren W.R. Mannitol excretion in galactosemic patients. Clin. Chim. Acta. 64:1975;39-44.
28. Sitzmann F.C., Schmid R.-D., Kaloud H. Excretion of galactitol in the urine of heterozygotes of both forms of galactosemia. Clin. Chim. Acta. 75:1977;313-319.
29. D/gt) after an oral galactose load. Clin. Chem. 31:1985;420-422.
30. Wehrli S.L., Berry G.T., Palmieri M., Mazur A., Elsas II L., Segal S. Urinary galactonate in patients with galactosemia: quantitation by nuclear magnetic resonance spectroscopy. Pediatr. Res. 42:1997;855-861.
31. Palmieri M., Mazur A., Berry G.T., Ning C., Wehrli S., Yager C., Reynolds R., Singh R., Muralidharan K., Langley S., Elsas II L., Segal S. Urine and plasma galactitol in patients with galactose-1-phosphate uridyltransferase deficiency galactosemia. Metabolism. 48:1999;1294-1302.
32. 14C] galactitol in mammalian tissue. Biochim. Biophys. Acta. 156:1968;9-16.
33. Cuatrecasas P., Segal S. Galactose conversion to D-xylulose: an alternate route of galactose metabolism. Science. 153:1966;549-551.
34. Bosch A.M., Prick L., Ter Horst N.M., van Gennip A.H., Wanders R.J.A., Duran M., Bakker H.D., Wijburg F.A. Oral galactose loading does not affect clinical or biochemical parameters in classical galactosemia. J. Inherit. Metab. Dis. 25(Suppl. 1):2002;129.
35. Walter J.H., Collins J.E., Leonard J.V. Recommendations for the management of galactosaemia. Arch. Dis. Child. 80:1999;93-96.